{
    "eid": "2-s2.0-85142519753",
    "title": "Major neurocognitive psychosis: a novel schizophrenia endophenotype class that is based on machine learning and resembles Kraepelin's and Bleuler's conceptions",
    "cover-date": "2022-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Psychiatry and Mental Health",
            "@code": "2738",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Biological Psychiatry",
            "@code": "2803",
            "@abbrev": "NEUR"
        }
    ],
    "keywords": [
        "inflammation",
        "neuroimmune",
        "oxidative stress",
        "psychiatry",
        "psychosis",
        "schizophrenia"
    ],
    "authors": [
        "Michael Maes"
    ],
    "citedby-count": 2,
    "ref-count": 77,
    "ref-list": [
        "Construction of a Neuro- Immune-Cognitive Pathway-Phenotype Underpinning the Phenome of Deficit Schizophrenia",
        "The Neuroimmune and Neurotoxic Fingerprint of Major Neurocognitive Psychosis or Deficit Schizophrenia: a Supervised Machine Learning Study",
        "Schizophrenia phenomenology revisited: positive and negative symptoms are strongly related reflective manifestations of an underlying single trait indicating overall severity of schizophrenia",
        "In schizophrenia, immuneinflammatory pathways are strongly associated with depressive and anxiety symptoms, which are part of a latent trait which comprises neurocognitive impairments and schizophrenia symptoms",
        "The Scale for the Assessment of Negative Symptoms (SANS): conceptual and theoretical foundations",
        "Eugen Bleuler's place in the history of psychiatry",
        "Schizophrenia: A conceptual history",
        "Correlation in restricted ranges of data",
        "Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis",
        "Global Epidemiology and Burden of Schizophrenia: Findings From the Global Burden of Disease Study 2016",
        "How to write up and report PLS analyses",
        "From prediction error to psychosis: ketamine as a pharmacological model of delusions",
        "Positive and negative schizophrenic symptoms and the role of dopamine",
        "How Kraepelinian was Kraepelin? How Kraepelinian are the neo- Kraepelinians?-from Emil Kraepelin to DSM-III",
        "Symptoms of psychosis",
        "Emil Kraepelin: A pioneer of scientific understanding of psychiatry and psychopharmacology",
        "Emil Wilhelm Magnus Georg Kraepelin (1856-1926)",
        "Consortium to Establish a Registry for Alzheimer's Disease (CERAD): the first twenty years",
        "Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017",
        "W. A practical guide to factorial validity using PLS-Graph: tutorial and annotated example",
        "A rating scale for depression",
        "Neuropsychological status of subjects at high risk for a first episode of psychosis",
        "A new criterion for assessing discriminant validity in variance-based structural equation modeling",
        "Suicide and schizophrenia: a systematic review of rates and risk factors",
        "Towards a new classification of stable phase schizophrenia into major and simple neuro-cognitive psychosis: Results of unsupervised machine learning analysis",
        "Deficit schizophrenia is a discrete diagnostic category defined by neuro-immune and neurocognitive features: results of supervised machine learning",
        "In Schizophrenia, Depression, Anxiety, and Physiosomatic Symptoms Are Strongly Related to Psychotic Symptoms and Excitation, Impairments in Episodic Memory, and Increased Production of Neurotoxic Tryptophan Catabolites: a Multivariate and Machine Learning Study",
        "Episodic memory and delayed recall are significantly more impaired in younger patients with deficit schizophrenia than in elderly patients with amnestic mild cognitive impairment",
        "The positive and negative syndrome scale (PANSS) for schizophrenia",
        "Cognitive impairment in schizophrenia",
        "Risk factors for the deficit syndrome of schizophrenia",
        "A separate disease within the syndrome of schizophrenia",
        "Epidemiology of schizophrenia: the global burden of disease and disability",
        "The diagnostic concept of schizophrenia: its history, evolution, and future prospects",
        "Balancing therapeutic safety and efficacy to improve clinical and economic outcomes in schizophrenia: a clinical overview",
        "False Dogmas in Schizophrenia Research: Toward the Reification of Pathway Phenotypes and Pathway Classes",
        "In (deficit) schizophrenia, a general cognitive decline partly mediates the effects of neuro-immune and neuro-oxidative toxicity on the symptomatome and quality of life",
        "In Schizophrenia, Deficits in Natural IgM Isotype Antibodies Including those Directed to Malondialdehyde and Azelaic Acid Strongly Predict Negative Symptoms, Neurocognitive Impairments, and the Deficit Syndrome",
        "Schizophrenia phenomenology comprises a bifactorial general severity and a single-group factor, which are differently associated with neurotoxic immune and immune-regulatory pathways",
        "In schizophrenia, psychomotor retardation is associated with executive and memory impairments, negative and psychotic symptoms, neurotoxic immune products and lower natural IgM to malondialdehyde",
        "Lowered Antioxidant Defenses and Increased Oxidative Toxicity Are Hallmarks of Deficit Schizophrenia: a Nomothetic Network Psychiatry Approach",
        "How to Construct a Bottom-Up Nomothetic Network Model and Disclose Novel Nosological Classes by Integrating Risk Resilience and Adverse Outcome Pathways with the Phenome of Schizophrenia",
        "Inflammatory and Oxidative Pathways Are New Drug Targets in Multiple Episode Schizophrenia and Leaky Gut, Klebsiella pneumoniae, and C1q Immune Complexes Are Additional Drug Targets in First Episode Schizophrenia",
        "Relationship of cognition and psychopathology to functional impairment in schizophrenia",
        "Eugen Bleuler's Dementia praecox or the group of schizophrenias (1911): a centenary appreciation and reconsideration",
        "Primary and Secondary Negative Symptoms in Schizophrenia",
        "Depression, Cytokine, and Cytokine by Treatment Interactions Modulate Gene Expression in Antipsychotic Na\u00efve First Episode Psychosis",
        "Executive functioning in schizophrenia",
        "The brief psychiatric rating scale",
        "Rethinking partial least squares path modeling: In praise of simple methods",
        "Structural equation modeling with the SmartPLS",
        "Sympt\u00f4mes positifs et n\u00e9gatifs de la schizophr\u00e9nie: une mise \u00e0 jour [Positive and negative symptoms in schizophrenia: a current overview]",
        "Correction for range restriction: an expanded typology",
        "Two faces of Emil Kraepelin",
        "Eotaxin, an Endogenous Cognitive Deteriorating Chemokine (ECDC), Is a Major Contributor to Cognitive Decline in Normal People and to Executive, Memory, and Sustained Attention Deficits, Formal Thought Disorders, and Psychopathology in Schizophrenia Patients",
        "The symptomatology, clinical forms and nosology of schizophrenia",
        "The forms of schizophrenia and their biological correlates",
        "First rank symptoms for schizophrenia",
        "The Reification of Diagnosis in Psychiatry",
        "How to construct neuroscience-informed psychiatric classification? Towards nomothetic networks psychiatry",
        "Diagnostic Task Specific Activations in Functional MRI and Aberrant Connectivity of Insula with Middle Frontal Gyrus Can Inform the Differential Diagnosis of Psychosis",
        "Heterogeneity of schizophrenia: Genetic and symptomatic factors",
        "Factors influencing teachers' intention to use technology: Model development and test",
        "Neurocognitive predictors of objective and subjective quality of life in individuals with schizophrenia: a meta-analytic investigation",
        "Quality of life and cognitive dysfunction in people with schizophrenia"
    ],
    "affiliation": [
        {
            "affiliation-city": "Plovdiv",
            "@id": "60031890",
            "affilname": "Medical University of Plovdiv",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031890",
            "affiliation-country": "Bulgaria"
        },
        {
            "affiliation-city": "Geelong",
            "@id": "60018805",
            "affilname": "Deakin University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018805",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}